Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
iotaMotion, Inc. · NCT06664710
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 10
- US sites recruiting
- 1
- Study start
- January 17, 2024
- Record last updated
- May 1, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluation of the Automated Integration of a Robotics and ECochG System for Use with Cochlear Implant Surgery
Being studied: iotaSOFT Insertion System with AIM; iotaSOFT Insertion System with AIM Control
Conditions: Hearing Loss, Sensorineural; Cochlear Implantation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Cochlear implant candidate in one or two ears per current FDA indications
- Sufficient residual hearing to support use of electrocochleography, as determined by the investigator
- Cochlear implantation using the Advanced Bionics SlimJ electrode array
- 18 years of age or older at the time of enrollment
- Willingness to participate in and comply with all requirements of the protocol
Exclusion Criteria
Contraindications for a CI. 2. Prior cochlear implantation in the ear to be implanted. 3. Cochlear ossification or malformation (including but not limited to dysplasia or common cavity), craniofacial abnormality or any other structural cochlear abnormality that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion.
- History of temporal bone fracture that involves the cochlea/internal auditory canal.
- Retrocochlear etiology (e.g. diagnosis of auditory neuropathy, cochlear nerve deficiency, or lesions of the acoustic nerve or central auditory pathway).
- Active middle-ear infection or tympanic membrane perforation in the presence of active middle ear disease.
- Planned or current participation in a clinical study of an investigational device or drug that may impact data collection or outcomes related to this investigation.
- Additional medical concerns that would prevent participation in evaluations as determined by the investigator.
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the procedure and investigational device.
- Vulnerable subject, as per FDA regulations 21 CFR Parts 50 and 56
Recruiting US locations
University of Iowa
Iowa City, IA 52242
Study contacts (from the official record)
- Laura Chenier, Director of Clinical Affairs, AuD · 442-325-4171 · lchenier@iotamotion.com
- Costa Nikou · cnikou@iotamotion.com